The conference is held co-located and concurrently with the SelectBIO Extracellular Vesicles 2022 Conference. All attendees receive full access to both tracks and the networking opportunities during the Food & Beverage events.
This 3D-Models: Organoids and Tissue Chips 2022 Conference focuses on the emerging tools for the ex vivo recapitulation of organ systems on board microfluidic chips and their utility for modeling physiological and disease processes in a controlled environment.
Additionally, technologies and tools for fabricating such systems ex vivo including organoids and tissue chips will be addressed during the conference.
There is a co-located exhibition with companies from around the world exhibiting on-site in person at the conference -- the focus therefore is on presentations from academic and industry speakers and exhibits by the companies offering tools, technologies, and services to the field.
Agenda:
Bioprinting using Microfluidics-based Approaches
Building Organoids from Various Tissue Classes (Brain, Gut, Lung, etc.) and Studies on these Organoids
Emerging Technologies for Reproducible Production of Organoids
Organ-on-a-Chip/Body-on-a-Chip Assembly using Microfluidics: Tools and Approaches
Spheroids - 3D Aggregates of Cells in Culture: Technologies and Applications
Tissue-on-a-Chip Applications for Drug Discovery and Toxicity Screening
Speakers:
Conference Chair
Albert Folch, Professor of Bioengineering, University of Washington
Keynote Speakers
Cole DeForest, Weyerhaeuser Endowed Professor, University of Washington
Noo Li Jeon, Professor, Seoul National University
Steven C. George, Professor and Chair, Department of Biomedical Engineering, University of California-Davis
John Rogers, Simpson/Querrey Professor of Materials Science and Engineering, Northwestern University
Nancy Allbritton, Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle
Matthias von Herrath, Vice President and Senior Medical Officer, Novo Nordisk, Professor, La Jolla Institute
Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)
Danilo Tagle, Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)
Elisabeth Verpoorte, Professor of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...